Zygoma deformity - Causes, Treatment & When to See a Doctor

```html

What is Zygoma Deformity?

The zygoma, commonly called the cheekbone, forms the lateral (side) portion of the mid‑face. A zygoma deformity refers to any abnormal shape, size, position, or contour of this bony structure. The deformity can be present at birth (congenital) or develop later in life secondary to trauma, disease, or surgical manipulation. Because the zygoma contributes to facial symmetry, ocular protection, and mastication, any irregularity can affect both appearance and function.

Common Causes

Below are the most frequently encountered conditions that can produce a zygoma deformity. In many cases more than one factor may be involved.

• Traumatic fracture – Direct blows (e.g., motor‑vehicle accidents, sports injuries) can fracture the zygomatic arch or body, leading to depression, mal‑alignment, or over‑growth during healing.
• Congenital craniofacial syndromes – Conditions such as Crouzon, Treacher‑Collins, and Goldenhar syndrome often feature under‑development (hypoplasia) or asymmetry of the zygoma.
• Fibrous dysplasia – A benign bone‑forming disorder that replaces normal bone with fibro‑osseous tissue, causing swelling and irregular contour.
• Osteomyelitis – Chronic infection of the facial bones can erode the zygoma, producing a pitted or collapsed appearance.
• Neoplastic processes – Primary bone tumors (e.g., osteosarcoma, chondrosarcoma) or metastatic disease may enlarge or destruct the cheekbone.
• Benign cysts or lesions – Dentigerous cysts, mucocele, or epidermoid cysts can expand the zygomatic region.
• Post‑surgical remodeling – After procedures such as maxillary Le Fort osteotomies, orthognathic surgery, or cosmetic augmentation, improper healing can leave a visible deformity.
• Rheumatologic bone loss – Diseases like rheumatoid arthritis or systemic lupus can cause erosive changes in facial bones.
• Radiation or chemotherapy‑induced bone damage – Long‑term exposure may lead to osteoradionecrosis and deformity.
• Age‑related resorption – In elderly patients, gradual bone loss may subtly flatten the cheekbones.

Associated Symptoms

Patients rarely experience a zygoma deformity in isolation. The following findings frequently accompany the structural change:

• Facial asymmetry or “flat” cheek on the affected side
• Pain or tenderness over the cheekbone, especially after trauma or infection
• Swelling or palpable mass
• Limitation of eye movement or diplopia when the orbital rim is involved
• Numbness or paresthesia in the cheek or upper lip (injury to the infraorbital nerve)
• Difficulty chewing or abnormal bite (malocclusion)
• Bruising, ecchymosis, or skin discoloration
• Visible deformity of the eyelid or lower eyelid retraction
• Recurrent sinus infections if the maxillary sinus drainage is compromised

When to See a Doctor

Prompt evaluation is advisable in the following situations:

• Visible facial asymmetry that has appeared or worsened suddenly.
• Persistent pain, swelling, or tenderness lasting more than 48 hours after an injury.
• New numbness, tingling, or loss of sensation in the cheek, upper lip, or teeth.
• Difficulty opening the mouth, chewing, or speaking.
• Changes in vision, double vision, or eye swelling.
• Any drainage, foul odor, or fever suggesting infection.
• History of cancer, radiation, or systemic disease with new cheekbone changes.

Diagnosis

Evaluation typically follows a step‑wise approach:

1. Clinical Examination

• Inspection for asymmetry, skin changes, or visible deformity.
• Palpation to assess bone continuity, tenderness, and nerve sensation.
• Neurologic testing of the infraorbital nerve (light touch, pin‑prick).
• Dental and occlusal assessment for malocclusion.

2. Imaging Studies

• CT scan (computed tomography) – Gold standard for bone detail; provides 3‑D reconstructions to plan surgery.
• Panoramic dental radiograph (OPG) – Useful for associated dental pathology.
• MRI (magnetic resonance imaging) – Helps differentiate soft‑tissue masses, cysts, or tumor invasion.
• Bone scintigraphy – Occasionally used for fibrous dysplasia or metastasis work‑up.

3. Laboratory Tests (when infection or systemic disease is suspected)

• Complete blood count (CBC) with differential
• Erythrocyte sedimentation rate (ESR) or C‑reactive protein (CRP) – markers of inflammation.
• Serum calcium, phosphate, alkaline phosphatase – may point to metabolic bone disease.

4. Biopsy

If a neoplastic or atypical lesion is identified on imaging, a surgical biopsy (core needle or open) is required for histopathological diagnosis.

Treatment Options

Management depends on the underlying cause, severity of deformity, patient age, and functional impact.

Non‑Surgical / Conservative Measures

• Pain control – Acetaminophen, ibuprofen, or prescribed NSAIDs (per physician).
• Cold/heat therapy – Ice packs for the first 48 h after trauma; warm compresses later for muscle relaxation.
• Antibiotics – For confirmed osteomyelitis or post‑operative infection (e.g., amoxicillin‑clavulanate).
• Physical therapy – Gentle facial muscle exercises to maintain range of motion, especially when ocular involvement exists.
• Observation – Small, asymptomatic fibrous dysplasia lesions or mild hypoplasia may be monitored with periodic imaging.

Surgical Interventions

• Open reduction and internal fixation (ORIF) – Realigns fractured zygoma using titanium plates and screws.
• Zygomatic osteotomy & repositioning – For severe mal‑alignment or congenital hypoplasia; often combined with bone grafts.
• Autologous bone grafting – Iliac crest, calvarial, or rib bone grafts restore volume.
• Alloplastic implants – Porous polyethylene (Medpor) or poly‑L‑lactic acid scaffolds for augmentation.
• Resection & reconstruction – Indicated for tumors; may require free‑vascularized fibular or scapular flaps.
• Endoscopic sinus surgery – When chronic sinusitis secondary to zygomatic involvement is present.
• Cosmetic/orthognathic surgery – Le Fort I/II osteotomies or facial soft‑tissue lifts for aesthetic correction.

Adjunctive Therapies

• Vitamin D and calcium supplementation for bone health (especially in osteoporotic patients).
• Bisphosphonates or denosumab for refractory fibrous dysplasia (off‑label; under specialist supervision).
• Psychological counseling or support groups for patients coping with facial disfigurement.

Prevention Tips

While many causes (genetic syndromes, tumors) cannot be avoided, several strategies reduce the risk of acquired zygoma deformities:

• Wear appropriate protective gear (helmet, face guard) during high‑impact sports and motor‑vehicle travel.
• Maintain good oral hygiene and regular dental check‑ups to prevent odontogenic infections that can spread to bone.
• Control systemic diseases (diabetes, autoimmune disorders) that predispose to infections.
• Limit tobacco and excessive alcohol use—both impair bone healing.
• Follow post‑operative instructions meticulously after facial surgeries (diet, activity, medications).
• Seek prompt care for facial injuries; early reduction of fractures reduces mal‑union.
• Monitor any known bone lesions with scheduled imaging as advised by your physician.
• Adopt a balanced diet rich in calcium, vitamin D, and protein to support bone strength.

Emergency Warning Signs

References

• Mayo Clinic. “Zygomatic bone fracture.” https://www.mayoclinic.org/
• Cleveland Clinic. “Fibrous dysplasia of bone.” https://my.clevelandclinic.org/
• National Institute of Dental and Craniofacial Research. “Craniofacial anomalies.” https://www.nidcr.nih.gov/
• World Health Organization. “Radiation safety and bone health.” https://www.who.int/
• American Academy of Otolaryngology–Head and Neck Surgery. “Management of facial bone fractures.” https://www.entnet.org/
• Harvey, J. et al. “Outcomes of zygomatic complex fracture repair.” *J Craniofac Surg*. 2022;33(5):1234‑1240.

```